Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 1

Status

Completed 4Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 51Rectal Neoplasms 27Colonic Neoplasms 16Stomach Neoplasms 14Carcinoma, Hepatocellular 14Neoplasm Metastasis 9Adenocarcinoma Of Esophagus 7Esophageal Neoplasms 6Neoplasms 5Cholangiocarcinoma 5Recurrence 3Pancreatic Neoplasms 3Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Adenocarcinoma 3Ovarian Neoplasms 2Liver Neoplasms 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cirrhosis, Familial, with Pulmonary Hypertension 2Biliary Tract Neoplasms 2Peritoneal Neoplasms 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neurotoxicity Syndromes 1Metastatic Colorectal Adenocarcinoma 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Locally Advanced Colorectal Carcinoma 1Intestinal Diseases 1

Interventions

Cisplatin 88Fluorouracil 71Paclitaxel 69Radiotherapy 63Oxaliplatin 55Irinotecan 37Docetaxel 36Carboplatin 36Leucovorin 34Capecitabine 28Radiation 25Surgical Procedures, Operative 22Drug Therapy 19pembrolizumab 18Cetuximab 15Bevacizumab 15Nivolumab 14tislelizumab 12camrelizumab 11Neoadjuvant Therapy 11Esophagectomy 11Chemoradiotherapy 11S 1 (combination) 10Albumin-Bound Paclitaxel 10nimotuzumab 9Trastuzumab 9durvalumab 8Radiotherapy, Intensity-Modulated 8Gefitinib 7Epirubicin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Esophageal Neoplasms × Folfox protocol × Clear all
NCT07603375 2026-05-22

TNT Esophagus

Duke University

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT02359968 2026-03-18

PROTECT

Centre Oscar Lambret

Phase 2 Completed
106 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00381706 2021-09-29

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
245 enrolled 15 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03528876 2020-11-02

LOGIC

University of Saskatchewan

Phase 2 Terminated
36 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT01498289 2019-11-07

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

SWOG Cancer Research Network

Phase 2 Completed
213 enrolled 17 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00004127 2013-02-11

Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

University of Chicago

Phase 2 Completed
35 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡